Estrogen Receptors
-
Elacestrant
Catalog No. A12244 Estrogen receptor degraderElacestrant (RAD1901) is an orally available selective estrogen receptor degrader (SERD) with IC50s of 48 and 870 nM for ERα and ERβ, respectively. 了解更多 -
GDC-0927 Racemate
Catalog No. A21507 estrogen receptor degraderGDC-0927 Racemate (SRN-927 Racemate) is a degrader of estrogen receptor, potently inhibits ER-α activity, with an IC50 of 0.2 nM, and is used in the research of ER-related diseases. 了解更多 -
RAD1901 HCl salt
Catalog No. A15990 SERD/SERMRAD1901 HCl salt是口服的选择性雌激素受体降解剂(SERD)和选择性雌激素受体调节剂(SERM),具有潜在的抗肿瘤活性和类似雌激素的活性。 了解更多 -
GDC-0810 (Brilanestrant)
Catalog No. A15958 Estrogen receptor degraderGDC-0810 (Brilanestrant)是一种口服可生物利用的选择性雌激素受体降解剂(SERD),在耐他莫昔芬的乳腺癌异种移植物中表现出强大的活性。 了解更多 -
PROTAC ERRα Degrader-1
Catalog No. A18910 ERRα DegraderPROTAC ERRα Degrader-1 comprises a MDM2 ligand binding group, a linker and an estrogen-related receptor alpha (ERRa) binding group. PROTAC ERRα Degrader-1 is an estrogen-related receptor alpha (ERRa) degrader. 了解更多 -
PROTAC ER Degrader-3
Catalog No. A18519 PROTAC ER Degrader-3 is an intermediate for synthesis of PAC. PAC, consists the ADCs linker and PROTACs, conjugated to an antibody. PAC extracts from patent WO2017201449A1, compound LP2. PAC conjugated to an antibody is a more marked estrogen receptor-alpha (ERα) degrader compared to PROTAC (without Ab). 了解更多